Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

34

Revenue 2017

Tivicay

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tivicay was produced by AbbVie and Eisai.

ViiV’s two-drug HIV combo backed by CHMP

ViiV’s two-drug HIV combo backed by CHMP The advisory committee issued a positive opinion for Juluca - which combines ViiV’s integrase inhibitor Tivicay (dolutegravir) with a non-nucleoside reverse transcriptase inhibitor Edurant (rilpivirine) developed by Johnson &Johnson’s

Gilead’s triple HIV drug approval prompts GSK lawsuit

Gilead’s triple HIV drug approval prompts GSK lawsuit The lawsuit has been submitted in the US and Canada and is seeking to prove that bictegravir infringes on intellectual property held by ViiV for its rival integrase inhibitor Tivicay (dolutegravir), ... forecasts. Tivicay and Triumeq posted strong growth

GSK’s ViiV gets US okay for two-drug HIV regimen

GSK’s ViiV gets US okay for two-drug HIV regimen Juluca is a combination of ViiV’s Tivicay and Janssen’s Edurant. The FDA has approved a dual therapy for HIV from GlaxoSmithKline’s ViiV joint venture with Johnson &Johnson, which ... Descovy was approved in the US last year and is often prescribed

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax Once again HIV therapies Tivicay (dolutegravir) and Triumeq (dolutegravir, abacavir and lamivudine) - up 45% to £1.47bn - led the advance amongst GSK’s prescription pharma business, with support from new asthma

ViiV files two-drug HIV maintenance regimen

ViiV files two-drug HIV maintenance regimen The company - majority-owned by GlaxoSmithKline - has filed for approval of a single tablet formulation containing integrase inhibitor Tivicay (dolutegravir) and the active ingredient in Janssen's non-nucleoside reverse transcriptase

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics